Blacklabel3
New Member
- Reaction score
- 0
this is a valid posting
Last edited:
Dont get excited by this its no real breakthrough since they dont have any idea yet how to use these findings in regards to making any treatments
In a report published Wednesday in the journal Science Translational Medicine, the authors noted that there were several drugs currently being developed to combat male pattern baldness, and a number of these drugs targeted the prostaglandin pathway. Cotsarelis said assuming the drugs pass muster regarding safety and other regulatory hurdles, they could lead to a cream or medication for male pattern baldness
s.a.f said:Its the best way ATM.
sir chugalot said:The bbc article says that drugs are in development, I think they have every idea about the next step.
the authors noted that there were several drugs currently being developed to combat male pattern baldness, and a number of these drugs targeted the prostaglandin pathway
Merck, based in Whitehouse Station, New Jersey, is testing laropiprant as a flushing inhibitor to be administered with niacin. Allschwil, Switzerland-based Actelion’s setipiprant is being studied as a treatment for allergic inflammation of nasal pathways. Both therapies are in the final phase of testing generally needed for regulatory approval.
Merck isn’t studying the anti-flushing drug in hair loss, said Ian McConnell, a Merck spokesman, in a telephone interview. “We haven’t seen any signals†in patient trials that the therapy might reduce baldness, he said.